Fulton Bank’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-8,754
| Closed | -$403K | – | 422 |
|
|
2016
Q3 | $403K | Sell |
8,754
-318
| -4% | -$14.6K | 0.04% | 290 |
|
|
2016
Q2 | $456K | Buy |
9,072
+367
| +4% | +$18.4K | 0.04% | 249 |
|
|
2016
Q1 | $465K | Buy |
8,705
+3,290
| +61% | +$176K | 0.05% | 246 |
|
|
2015
Q4 | $355K | Sell |
5,415
-108
| -2% | -$7.08K | 0.04% | 262 |
|
|
2015
Q3 | $312K | Sell |
5,523
-6,083
| -52% | -$344K | 0.04% | 272 |
|
|
2015
Q2 | $686K | Buy |
11,606
+96
| +0.8% | +$5.67K | 0.07% | 194 |
|
|
2015
Q1 | $717K | Buy |
11,510
+3,617
| +46% | +$225K | 0.08% | 193 |
|
|
2014
Q4 | $454K | Buy |
7,893
+216
| +3% | +$12.4K | 0.05% | 223 |
|
|
2014
Q3 | $413K | Sell |
7,677
-396
| -5% | -$21.3K | 0.05% | 223 |
|
|
2014
Q2 | $423K | Sell |
8,073
-54
| -0.7% | -$2.83K | 0.05% | 224 |
|
|
2014
Q1 | $429K | Sell |
8,127
-1,912
| -19% | -$101K | 0.05% | 213 |
|
|
2013
Q4 | $402K | Sell |
10,039
-633
| -6% | -$25.3K | 0.05% | 218 |
|
|
2013
Q3 | $403K | Sell |
10,672
-13,378
| -56% | -$505K | 0.05% | 225 |
|
|
2013
Q2 | $943K | Buy |
+24,050
| New | +$943K | 0.12% | 133 |
|